z-logo
open-access-imgOpen Access
Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer
Author(s) -
Yiyan Jiang,
Ting Qian,
SuXia Li,
Yuanyuan Xie,
Min Tao
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-795
Subject(s) - pi3k/akt/mtor pathway , cell growth , tamoxifen , cancer research , metformin , gas5 , gene knockdown , mcf 7 , downregulation and upregulation , apoptosis , pten , chemistry , biology , cancer cell , cancer , medicine , endocrinology , breast cancer , insulin , long non coding rna , biochemistry , human breast , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom